Skip to main content
. 2000 Mar;49(3):264–268. doi: 10.1046/j.1365-2125.2000.00127.x

Table 1.

Characteristics of pregnant women having obtained a prescription for metoclopramide at the pharmacy and women without exposureto any reimbursed, prescribed medications and outcome of birth.

Variable Exposure only in interval 11 Exposure only in interval 22 Exposure at any time in interval 1 or 23 References not exposed4
Number of pregnancies 190 295 309 13327
Number of prescriptions 239 428 443 -
Maternal mean age, years 27.9 27.5 27.5 27.8
Range, years 18–41 17–41 17–41 13–47
Smokers, % 19.4 24.1 24.6 28.9
Birth order, no. 1 79 130 136 7472
Birth order, > no. 1 111 165 173 5855
Gestational age (weeks)
 ≥ 37 weeks 176 278 292 12534
 34–36 weeks 9 10 10 540
 < 34 weeks 5 7 7 253
Mean birth weight, g 3489 3480 3483 3470
Range, g 883–5530 883–5530 883–5530 500–5520
Number of malformations 11 15 16 697
Number of low birth weight 11 18/7** 18 657/209**
Number of preterm deliveries 14 17 17 793
Number of stillborn (before birth) 0 1 1 31
Number of stillborn (during birth) 1 1 1 15
**

restricted to full-term deliveries.

1

Exposed to metoclopramide 30 days before conception to end of 1st trimester.

2

Exposed to metoclopramide in 2nd or 3rd trimester.

3

Exposed to metoclopramide at any time from 30 days before conception to delivery.

4

Reference pregnancies not exposed to any prescribed, reimbursed drugs at any time during pregnancy.